跳至主要内容
临床试验/NCT05516641
NCT05516641Unknown不适用

Do Prebiotics Change Intestinal Biome in Rectal Cancer Patients Undergoing Neoadjuvant Therapy

Ochsner Health System2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年7月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
Gut Flora modulation

研究概览

简要总结

A significant racial disparity in the incidence and mortality of CRC exists in the U.S. with African Americans having CRC incidence and mortality rates that are 20% and 40% higher than the general U.S. population. It has been demonstrated that the gut microbiome impacts tumor development and progression through multiple mechanisms, including impacting the tumoral immune response. However, it is unknown if microbiome modulating treatment can have an impact on CRC outcomes.

详细描述

A significant racial disparity in the incidence and mortality of CRC exists in the U.S. with African Americans having CRC incidence and mortality rates that are 20% and 40% higher than the general U.S. population. It has been demonstrated that the gut microbiome impacts tumor development and progression through multiple mechanisms, including impacting the tumoral immune response. However, it is unknown if microbiome modulating treatment can have an impact on CRC outcomes.

This is a pilot project to see if any changes are detected in stool and/or tissue samples in rectal cancer patients who receive a soluble corn fiber supplement during their neoadjuvant treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Clinical diagnosis of stage 2 or stage 3 rectal cancer
  • Subjects who are women of child-bearing potential must not be pregnant or lactating
  • Have signed an approved informed consent form for the study
  • Be willing to comply with the protocol

排除标准

  • Patients with a cancer history (excluding the rectal cancer currently being addressed)
  • Allergic to corn or maltodextrin
  • Has, in the Investigator's opinion, any medical condition that makes the subject a poor candidate for the study

结局指标

主要结局

Gut Flora modulation

时间窗: 1 year

fiber supplements with prebiotic effects modulate the gut and tumor associated microbiome leading to improved outcomes in stage II and III rectal cancer patients

次要结局

  • Immune Profile(6 months)
  • Microbiome changes(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验